Ingevity vs OLIN
NGVT and OLN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NGVT and OLN compare
Ingevity and OLIN are about the same size, with market caps of $2.2B and $2.0B.
OLIN grew revenue faster over the last twelve months (−0.73% versus −3.7% for Ingevity).
Ingevity keeps more of each dollar of sales as profit, with a net margin of 5.3% compared with −3.3% at OLIN.
OLIN pays a dividend yielding 4.5%; Ingevity does not pay one.
OLIN scores higher on the StockData Score (10 against 6 for Ingevity), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NGVT | OLN |
|---|---|---|
| Size and price | ||
| Market cap | $2.2B | $2.0B |
| Share price | $63.24 | $17.89 |
| Change, 1 year | 26.8% | −7.5% |
| Change, 5 years | −19.8% | −70.3% |
| Beta (5Y) | 1.21 | 1.14 |
| Employees | 1,500 | 7,849 |
| StockData Score | ||
| Total score | 6 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 3 (better) | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 5 (better) |
| Valuation | ||
| P/E | 37.2× | – |
| P/S | 1.9× | 0.3× (better) |
| P/B | 34.5× | 1.2× (better) |
| EV/EBITDA | 23.4× | 13.8× (better) |
| P/FCF | 17.7× | 9.2× (better) |
| FCF yield | 5.6% | 10.9% (better) |
| Fair value | $35.84 | $37.61 |
| Margin of safety | −76.5% | 52.4% (better) |
| Growth | ||
| Revenue growth (TTM) | −3.7% | −0.73% (better) |
| Revenue growth, 5Y average | −0.81% | 3.3% (better) |
| Net income growth (TTM) | – | −531% |
| EPS growth (TTM) | – | −535% |
| Profitability | ||
| Gross margin | 42.0% (better) | 6.7% |
| Operating margin | – | −1.9% |
| Net margin | 5.3% (better) | −3.3% |
| FCF margin | 10.8% (better) | 3.3% |
| Return on equity | 59.5% (better) | −12.2% |
| Return on invested capital | – | −2.2% |
| Financial health | ||
| Debt / equity | 18.18 | 1.75 (better) |
| Net debt / EBITDA | 7.68 (better) | 7.99 |
| Interest coverage | – | −0.7× |
| Current ratio | 1.48 (better) | 1.45 |
| Altman Z-score | 2.31 (better) | 1.55 |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | – | 4.5% |
| Buyback yield | 7.2% (better) | 0.50% |
| Shareholder yield | 7.2% (better) | 5.0% |
| Ownership | ||
| Held by institutions | 102% | 99.8% |
| Held by insiders | 1.4% | 0.44% |
| Insider net buying, 12 months | −$1.8M (better) | −$2.4M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 3.7% | 12.2% |
Go deeper
- NGVT stock overview
- NGVT income statement
- NGVT valuation and score
- OLN stock overview
- OLN income statement
- OLN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.